Birch Grove Capital LP - Q4 2016 holdings

$114 Million is the total value of Birch Grove Capital LP's 18 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 77.8% .

 Value Shares↓ Weighting
 VECTOR GROUP LTDnote 1.750% 4/1$30,896,000
+1.6%
26,606,0000.0%27.10%
-5.0%
SellAMAG PHARMACEUTICALS INCnote 2.500% 2/1$14,144,000
-27.8%
10,000,000
-42.0%
12.41%
-32.5%
 SHUTTERFLY INCnote 0.250% 5/1$11,832,000
+2.6%
11,636,0000.0%10.38%
-4.0%
NewVITAMIN SHOPPE INCnote 2.250% 12/0$11,345,00012,000,000
+100.0%
9.95%
 ALBANY MOLECULAR RESH INCnote 2.250% 11/1$11,071,000
+9.8%
8,500,0000.0%9.71%
+2.7%
SellWEBMD HEALTH CORPnote 2.500% 1/3$10,263,000
-10.5%
10,000,000
-9.1%
9.00%
-16.3%
SellDHT HOLDINGS INCdebt 4.500% 10/0$9,440,000
-22.9%
10,000,000
-25.7%
8.28%
-27.9%
NewSHIP FINANCE INTERNATIONALnote 5.750% 10/1$8,035,0008,000,000
+100.0%
7.05%
GPIA NewGP INVTS ACQUISITION COR$5,450,000544,480
+100.0%
4.78%
HIL SellHILL INTERNATIONAL INC$423,000
-52.3%
97,302
-49.4%
0.37%
-55.4%
HCACW  HENNESSY CAP ACQUISITION COR*w exp 07/28/202$347,000
+112.9%
408,5100.0%0.30%
+98.7%
ELECW  ELECTRUM SPL ACQUISITION CORP*w exp 99/99/999$298,000
+14.6%
531,8580.0%0.26%
+7.0%
HP NewHELMERICH & PAYNE INCput$168,000140,000
+100.0%
0.15%
EACQW  EASTERY ACQUISITION CORP*w exp 07/29/202$130,000
-41.4%
370,0000.0%0.11%
-45.2%
GPIAW  GP INVTS ACQUISITION COR*w exp 05/19/202$94,000
-31.9%
206,1100.0%0.08%
-36.4%
VRX NewVALEANT PHARMACEUTICALS INTLcall$37,00020,000
+100.0%
0.03%
BKD NewBROOKDALE SR LIVING INCcall$9,00057,400
+100.0%
0.01%
GILD NewGILEAD SCIENCES INCcall$8,00020,000
+100.0%
0.01%
ExitBROOKDALE SR LIVING INCcall$0-57,400
-100.0%
-0.01%
ExitSHIP FINANCE INTERNATIONALput$0-200,000
-100.0%
-0.04%
ExitGILEAD SCIENCES INCcall$0-20,000
-100.0%
-0.05%
ExitAMAG PHARMACEUTICALS INCput$0-207,000
-100.0%
-0.06%
ExitVALEANT PHARMACEUTICALS INTLcall$0-20,000
-100.0%
-0.14%
AAPC ExitATLANTIC ALLIANCE PARTNER CO$0-379,800
-100.0%
-3.74%
GPIAU ExitGP INVTS ACQUISITION CORunit 99/99/9999$0-544,480
-100.0%
-4.96%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST13Q3 20231.3%
GOLAR LNG LTD12Q4 202011.3%
MULTIPLAN CORPORATION12Q3 20230.3%
TABULA RASA HEALTHCARE INC11Q3 202343.7%
JAZZ INVESTMENTS I LTD11Q3 202322.4%
KAMAN CORP11Q1 20239.7%
VECTOR GROUP LTD10Q1 201828.5%
NUANCE COMMUNICATIONS INC10Q4 201918.7%
JAZZ INVESTMENTS I LTD10Q1 202020.9%
ALLSCRIPTS HEALTHCARE SOLUTN10Q3 201910.8%

View Birch Grove Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Birch Grove Capital LP Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Independence Contract Drilling, Inc.April 17, 2020? ?
Easterly Acquisition Corp.September 29, 2016? ?

View Birch Grove Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR/A2023-05-22
13F-HR/A2023-05-22
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-17

View Birch Grove Capital LP's complete filings history.

Compare quarters

Export Birch Grove Capital LP's holdings